X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1470) 1470
Publication (115) 115
Government Document (29) 29
Dissertation (27) 27
Book Review (16) 16
Book Chapter (13) 13
Conference Proceeding (10) 10
Magazine Article (3) 3
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
her2/neu (985) 985
humans (962) 962
female (731) 731
oncology (655) 655
breast cancer (579) 579
index medicus (436) 436
receptor, erbb-2 - metabolism (352) 352
cancer (331) 331
trastuzumab (315) 315
middle aged (314) 314
immunohistochemistry (307) 307
breast neoplasms - pathology (289) 289
animals (274) 274
aged (263) 263
her2 (263) 263
expression (255) 255
adult (244) 244
receptor, erbb-2 - genetics (242) 242
breast neoplasms - metabolism (234) 234
mice (212) 212
prognosis (205) 205
neu (204) 204
breast neoplasms - drug therapy (186) 186
monoclonal-antibody (181) 181
carcinoma (179) 179
cell line, tumor (179) 179
breast neoplasms - genetics (171) 171
chemotherapy (160) 160
her2/neu-overexpressing metastatic breast (160) 160
pathology (159) 159
overexpression (158) 158
male (155) 155
antibodies, monoclonal, humanized (152) 152
breast-cancer (148) 148
her-2/neu (146) 146
receptor, erbb-2 - immunology (140) 140
aged, 80 and over (135) 135
gene amplification (135) 135
therapy (135) 135
antineoplastic agents - therapeutic use (130) 130
in-situ hybridization (124) 124
ovarian-cancer (124) 124
amplification (123) 123
research (123) 123
tumors (122) 122
immunology (115) 115
cell biology (113) 113
antibodies, monoclonal - therapeutic use (112) 112
biochemistry & molecular biology (112) 112
skin and connective tissue diseases (109) 109
receptor, erbb-2 - analysis (108) 108
phase-ii (107) 107
apoptosis (106) 106
survival (106) 106
tumor cells, cultured (106) 106
immunotherapy (105) 105
medicine & public health (104) 104
receptor, erbb-2 - biosynthesis (103) 103
cells (101) 101
genes, erbb-2 (99) 99
care and treatment (97) 97
in situ hybridization, fluorescence (96) 96
neoplasm staging (95) 95
gene expression regulation, neoplastic (94) 94
analysis (92) 92
oncogene (92) 92
proteins (92) 92
metastasis (91) 91
growth-factor receptor (90) 90
neu oncogene (87) 87
receptor (87) 87
antineoplastic agents - pharmacology (86) 86
breast neoplasms - therapy (86) 86
genetic aspects (86) 86
gene expression (84) 84
health aspects (82) 82
medicine, research & experimental (79) 79
protein (79) 79
epidermal growth factor (75) 75
erbb2 (74) 74
neoplasms (74) 74
pharmacology & pharmacy (73) 73
in-vivo (72) 72
retrospective studies (72) 72
treatment outcome (71) 71
article (69) 69
growth (68) 68
receptor, erbb-2 - antagonists & inhibitors (68) 68
biomarkers, tumor - analysis (67) 67
dendritic cells (67) 67
p53 (65) 65
breast neoplasms - immunology (64) 64
c-erbb-2 (63) 63
biomarkers, tumor - metabolism (62) 62
genetics & heredity (62) 62
signal transduction (61) 61
herceptin (59) 59
surgery (59) 59
antibodies, monoclonal - pharmacology (57) 57
development and progression (57) 57
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1470) 1470
Chinese (23) 23
Spanish (16) 16
French (11) 11
German (9) 9
Polish (5) 5
Japanese (4) 4
Korean (3) 3
Russian (3) 3
Hungarian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 17, pp. 7819 - 7824
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 06/2009, Volume 50, Issue 6, pp. 974 - 981
The anti-human epidermal growth factor receptor 2 (HER2/neu) antibody trastuzumab is administered to patients with HER2/neu-overexpressing breast cancer.... 
TARGET | PROTEIN | TRASTUZUMAB | C-ERBB2 | BEARING NUDE-MICE | breast cancer | HER2/neu | imaging | immunoPET | THERAPY | BREAST-CANCER XENOGRAFTS | MONOCLONAL-ANTIBODIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | ANTIGEN
Journal Article
NUCLEAR MEDICINE AND BIOLOGY, ISSN 0969-8051, 01/2013, Volume 40, Issue 1, pp. 3 - 14
The advent of antibody-based cancer therapeutics has led to the concomitant rise in the development of companion diagnostics for these therapies, particularly... 
ImmunoPET | IMMUNO-PET | HER2/NEU EXPRESSION | Antibody | BEARING NUDE-MICE | ZIRCONIUM COMPLEXES | P-ISOTHIOCYANATOBENZYL-DESFERRIOXAMINE | POSITRON-EMISSION-TOMOGRAPHY | BIFUNCTIONAL CHELATE | Radiochemistry | IN-VIVO | GROWTH-FACTOR | PET Imaging | MONOCLONAL-ANTIBODIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Zr-89
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4248 - 4254
Purpose: In phase I/II studies, nelipepimutS (NPS) plus GMCSF vaccine was well tolerated and effectively raised HER2specific immunity in patients with breast... 
IMMUNIZATION | HER2/NEU E75 VACCINE | GROUP-STUDY I-01 | THERAPY | TRASTUZUMAB | ONCOLOGY | GUIDELINES | IMMUNE-RELATED RESPONSE | HER-2/NEU | AMERICAN SOCIETY | PEPTIDE
Journal Article
Acta Naturae, ISSN 2075-8251, 2015, Volume 7, Issue 3, pp. 133 - 139
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 2, pp. 421 - 425
Journal Article
Salus, ISSN 1316-7138, 08/2015, Volume 19, Issue 2, pp. 20 - 25
Journal Article
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 94, p. 36652
Journal Article
Journal Article
Voprosy Onkologii, ISSN 0507-3758, 2017, Volume 63, Issue 4, pp. 657 - 659
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1659 - 1672
Journal Article